NCT04815148 - MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions

Atopic DermatitisRheumatoid Arthritis

Interventions

DRUG

MH004 Ia(0.1%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(0.3%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(1%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(3%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ib-1(0.1%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-1(0.3%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-1(1%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-2(0.3%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.

DRUG

MH004 Ib-2(1%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.

DRUG

MH004 Ib-2(3%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.